Articles

The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product. 

 Genezen Purchases uniQure’s Gene Therapy Operations in Massachusetts

A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes. 

Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic

The CRDMO will contribute cell discovery services that will benefit clinical development of novel technologies.

Aurigene, Edity Introduce Cell Therapy Collaboration

Following the evaluation, the company will decide whether it wants to move forward with the IDMO’s automated, end-to-end, cell therapy manufacturing platform. 

Kite to Assess Cellares’ Automated Manufacturing Platform

The company’s latest investment—featuring new cGMP suites at its Devens, MA plant—is valued at $30 million.

Veranova Expands Its Financial Commitment Toward Growing Highly Potent API Services

The North Carolina project adds 1.4 million square feet of dedicated production space for aseptic manufacturing and finished production processes.

Novo Nordisk Financially Commits $4.1 Billion Toward Growing US Manufacturing Capabilities

A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.

Barriers Encountered by Patients While Making Cancer Care Clinic Appointments

The deal offers member pharmacies two pricing options, which will take effect Aug. 1.

McKesson, Independent Pharmacy Cooperative Reach Drug Supply Agreement

A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.

The Association Between 340B Program Involvement and Availability of Hospital Services

The agreement will look to further develop cell and gene therapies for the treatment of hematological cancers.

News